Skip to content

melatonin/Finding

One finding, on its own

A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.

  • melatonin — no detected effect on lean body mass

    Evidence strength: very limited.FindingNull result
    “Total fat content, total lean body mass, body weight, total bone mineral content, total bone mineral density (BMD), lumbar spine BMD, and total hip BMD were not significantly different after M compared with P (Table 2).”
    Quoted verbatim from Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes-A randomized placebo-controlled crossover trial..
    Study
    crossover
    Duration
    3 months
    Dose
    10 mg melatonin 1 h before bedtime for 12 weeks
    Population
    Seventeen men with type 2 diabetes on stable antidiabetic, antihypertensive and lipid-lowering therapy; double-blind placebo-controlled crossover; whole-body DEXA at end of each 12-week period; secondary endpoint

    Three months of melatonin treatment reduces insulin sensitivity in patients with type 2 diabetes-A randomized placebo-controlled crossover trial.2022PMID:3561922110.1111/jpi.12809Permalink

To cite this finding: https://catalystproject.ai/e/01M5JVZW68N33EA1ZK8S7JEWYF

Keep reading